Literature DB >> 7582241

Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells.

J F Emile1, S Fraitag, P Andry, M Leborgne, A Lellouch-Tubiana, N Brousse.   

Abstract

Langerhans' cell histiocytosis (LCH) is characterized by the proliferation of large mononucleated cells containing Birbeck granules and expressing CD1a. Recent studies have demonstrated that LCH is a clonal proliferation; however, its aetiology is still unknown. Growth and differentiation of bone-marrow-derived cells are controlled by cytokines. The proliferation, differentiation and activation of normal Langerhans cells are controlled by granulocyte/macrophage colony-stimulating factor (GM-CSF) in vitro. Therefore, GM-CSF could be implicated in the pathogenesis of LCH. Indeed, LCH cells contain GM-CSF, and children with disseminated LCH have an elevated GM-CSF serum level. As a cytokine only acts on cells expressing a specific receptor, we investigated the presence of GM-CSF receptor on LCH cells. Fourteen frozen tissue samples from children with LCH were studied by in situ immunohistochemistry with two mouse monoclonal antibodies specific for the alpha chain of the GM-CSF receptor (CDw116). LCH cells of all the samples were positively stained with both antibodies. This study suggests that GM-CSF may be a growth factor for LCH cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582241     DOI: 10.1007/BF00196516

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

Review 1.  Langerhans' cell histiocytosis and malignancies of the M-PIRE system.

Authors:  J M Ben-Ezra; C H Koo
Journal:  Am J Clin Pathol       Date:  1993-04       Impact factor: 2.493

2.  Langerhans' cell histiocytosis cells are activated Langerhans' cells.

Authors:  J F Emile; S Fraitag; M Leborgne; Y de Prost; N Brousse
Journal:  J Pathol       Date:  1994-10       Impact factor: 7.996

3.  Electron microscopy in histiocytosis X.

Authors:  G W Mierau; B E Favara; J M Brenman
Journal:  Ultrastruct Pathol       Date:  1982 Apr-Jun       Impact factor: 1.094

4.  Reactivity of histiocytosis X cells with monoclonal anti-T6 antibody.

Authors:  S Chollet; P Dournovo; M S Richard; P Soler; F Basset
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

5.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

6.  Three conserved motifs in the extracellular domain of the human granulocyte-macrophage colony-stimulating factor receptor subunit are essential for ligand binding and surface expression.

Authors:  P D Doshi; J F DiPersio
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

7.  Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

Authors:  C L Willman; L Busque; B B Griffith; B E Favara; K L McClain; M H Duncan; D G Gilliland
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

8.  Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.

Authors:  M D Witmer-Pack; W Olivier; J Valinsky; G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.

Authors:  G Kaplan; G Walsh; L S Guido; P Meyn; R A Burkhardt; R M Abalos; J Barker; P A Frindt; T T Fajardo; R Celona
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  4 in total

1.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

2.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

3.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  Lycopus lucidus Turcz ameliorates DNCB‑induced atopic dermatitis in BALB/c mice.

Authors:  Ga-Yul Min; Eun-Young Kim; Sooyeon Hong; Jae-Hyun Kim; Minsun Kim; Eom Ji Kim; Jae Ho Park; Youngjoo Sohn; Hyuk-Sang Jung
Journal:  Mol Med Rep       Date:  2021-09-28       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.